NLRP3 and immune system disorder: These studies demonstrate the occurrence of crosstalk between the NLRP3 inflammasome and mtROS and suggest that targeting mtROS by the elimination of damaged mitochondria could be a promising therapeutic strategy for NLRP3 inflammasome-related immune disorders.